EMPLOYMENT AGREEMENTEmployment Agreement • August 7th, 2018 • Quotient LTD • In vitro & in vivo diagnostic substances
In connection with the ongoing employment agreement (“Employment Agreement”) between Quotient Limited (“Employer”) and Christopher Lindop (Executive) (collectively the “Parties”) dated February 9, 2017, the Parties agree as of April 5, 2018 to amend paragraph 4 of the Agreement as follows:
AMENDMENT NO. 1 TO ROYALTY RIGHT AGREEMENTRoyalty Right Agreement • August 7th, 2018 • Quotient LTD • In vitro & in vivo diagnostic substances • New York
Reference is hereby made to that certain Royalty Right Agreement dated October 14, 2016 by and between Quotient Limited, a public limited liability company formed under the Laws of Jersey, Channel Islands (the “Seller”) and the Purchaser named on the signature page thereto (the “Existing Royalty Right Agreement”).The Seller and the Purchaser are each referred to in this Amendment No. 1 to Royalty Right Agreement (this “Amendment”) as a “Party” and are collectively referred to in this Amendment as the “Parties”. Capitalized terms used herein and not defined shall have the meaning ascribed to each in the Royalty Right Agreement. The rules of construction set forth in Annex A to the Royalty Right Agreement shall apply to this Amendment mutatis mutandis and are hereby incorporated by reference into this Amendment as if set forth fully in this Amendment.
